Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hongxiang Hu

Showing results (61-70 of 64) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 64 results.
Molecular Therapy : the Journal of the American Society of Gene Therapy|September 10, 2022
Feasibility and preclinical efficacy of CD7-unedited CD7 CAR T cells for T cell malignanciesNorihiro Watanabe, Feiyan Mo, Rong Zheng, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 18, 2018
Mitigating SOX2-potentiated Immune Escape of Head and Neck Squamous Cell Carcinoma with a STING-inducing Nanosatellite VaccineYee Sun Tan, Kanokwan Sansanaphongpricha, Yuying Xie, et al.
ACS Nano|March 21, 2024
Antigen-Clustered Nanovaccine Achieves Long-Term Tumor Remission by Promoting B/CD 4 T Cell CrosstalkChengyi Li, Ryan Clauson, Luke F Bugada, et al.
Blood|June 3, 2026
Arlocabtagene autoleucel-a GPRC5D-targeted CAR T-cell therapy in heavily pretreated relapsed/refractory multiple myelomaSusan Bal, Myo Htut, Omar Nadeem, et al.
Pageof 7

Showing results (61-70 of 64) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 64 results.
Molecular Therapy : the Journal of the American Society of Gene Therapy|September 10, 2022
Feasibility and preclinical efficacy of CD7-unedited CD7 CAR T cells for T cell malignanciesNorihiro Watanabe, Feiyan Mo, Rong Zheng, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 18, 2018
Mitigating SOX2-potentiated Immune Escape of Head and Neck Squamous Cell Carcinoma with a STING-inducing Nanosatellite VaccineYee Sun Tan, Kanokwan Sansanaphongpricha, Yuying Xie, et al.
ACS Nano|March 21, 2024
Antigen-Clustered Nanovaccine Achieves Long-Term Tumor Remission by Promoting B/CD 4 T Cell CrosstalkChengyi Li, Ryan Clauson, Luke F Bugada, et al.
Blood|June 3, 2026
Arlocabtagene autoleucel-a GPRC5D-targeted CAR T-cell therapy in heavily pretreated relapsed/refractory multiple myelomaSusan Bal, Myo Htut, Omar Nadeem, et al.
Pageof 7